123 related articles for article (PubMed ID: 37156336)
1. Crosstalking interactions between P2X4 and 5-HT
Chang-Halabi Y; Cordero J; Sarabia X; Villalobos D; Barrera NP
Neuropharmacology; 2023 Sep; 236():109574. PubMed ID: 37156336
[TBL] [Abstract][Full Text] [Related]
2. A New Mechanism of Receptor Targeting by Interaction between Two Classes of Ligand-Gated Ion Channels.
Emerit MB; Baranowski C; Diaz J; Martinez A; Areias J; Alterio J; Masson J; Boué-Grabot E; Darmon M
J Neurosci; 2016 Feb; 36(5):1456-70. PubMed ID: 26843630
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.
Nishtala SN; Mnatsakanyan N; Pandhare A; Leung C; Jansen M
J Neurochem; 2016 May; 137(4):528-38. PubMed ID: 26875553
[TBL] [Abstract][Full Text] [Related]
4. Function of P2X4 Receptors Is Directly Modulated by a 1:1 Stoichiometric Interaction With 5-HT
Soto P; Gaete PS; Fuentes C; Lozano B; Naulin PA; Figueroa XF; Barrera NP
Front Cell Neurosci; 2020; 14():106. PubMed ID: 32431598
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
6. SR 57227A is a partial agonist/partial antagonist of 5-HT
Nakamura Y; Kondo M; Koyama Y; Shimada S
Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a 5-HT
Price KL; Lummis SCR
ACS Chem Neurosci; 2018 Jun; 9(6):1409-1415. PubMed ID: 29508995
[TBL] [Abstract][Full Text] [Related]
8. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
9. Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
Ladefoged LK; Munro L; Pedersen AJ; Lummis SCR; Bang-Andersen B; Balle T; Schiøtt B; Kristensen AS
Mol Pharmacol; 2018 Dec; 94(6):1421-1434. PubMed ID: 30257860
[TBL] [Abstract][Full Text] [Related]
10. P2X
Fois G; Föhr KJ; Kling C; Fauler M; Wittekindt OH; Dietl P; Frick M
J Physiol; 2018 Oct; 596(20):4893-4907. PubMed ID: 30144063
[TBL] [Abstract][Full Text] [Related]
11. Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes.
Na JH; Shin J; Jung Y; Lim D; Shin YK; Yu YG
Protein Expr Purif; 2013 Apr; 88(2):190-5. PubMed ID: 23321066
[TBL] [Abstract][Full Text] [Related]
12. Modulation of 5-HT3 receptor-mediated response and trafficking by activation of protein kinase C.
Sun H; Hu XQ; Moradel EM; Weight FF; Zhang L
J Biol Chem; 2003 Sep; 278(36):34150-7. PubMed ID: 12791692
[TBL] [Abstract][Full Text] [Related]
13. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization.
Xiong W; Hosoi M; Koo BN; Zhang L
Mol Pharmacol; 2008 Feb; 73(2):314-22. PubMed ID: 17993512
[TBL] [Abstract][Full Text] [Related]
14. Pathways and Barriers for Ion Translocation through the 5-HT3A Receptor Channel.
Di Maio D; Chandramouli B; Brancato G
PLoS One; 2015; 10(10):e0140258. PubMed ID: 26465896
[TBL] [Abstract][Full Text] [Related]
15. Cross-Talk between P2X and NMDA Receptors.
Rodriguez L; Yi C; Chu C; Duriez Q; Watanabe S; Ryu M; Reyes B; Asatryan L; Boué-Grabot E; Davies D
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003406
[TBL] [Abstract][Full Text] [Related]
16. Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain.
Williams WA; Linley JE; Jones CA; Shibata Y; Snijder A; Button J; Hatcher JP; Huang L; Taddese B; Thornton P; Schofield DJ; Thom G; Popovic B; Dosanjh B; Wilkinson T; Hughes J; Dobson CL; Groves MA; Webster CI; Billinton A; Vaughan TJ; Chessell I
Pain; 2019 Sep; 160(9):1989-2003. PubMed ID: 31045747
[TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of Human Serotonin Receptor Type 3A by Chanoclavine and Ergonovine.
Eom S; Jung W; Lee J; Yeom HD; Lee S; Kim C; Park HD; Lee JH
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668306
[TBL] [Abstract][Full Text] [Related]
18. Which agonist properties are important for the activation of 5-HT3A receptors?
Meiboom MF; Barann M; Witten S; Groeneveld K; Urban BW
Biochim Biophys Acta; 2013 Nov; 1828(11):2564-73. PubMed ID: 23792067
[TBL] [Abstract][Full Text] [Related]
19. Microsecond-timescale simulations suggest 5-HT-mediated preactivation of the 5-HT
Guros NB; Balijepalli A; Klauda JB
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):405-414. PubMed ID: 31871207
[TBL] [Abstract][Full Text] [Related]
20. Neurosteroids as positive and negative allosteric modulators of ligand-gated ion channels: P2X receptor perspective.
Sivcev S; Kudova E; Zemkova H
Neuropharmacology; 2023 Aug; 234():109542. PubMed ID: 37040816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
